Found 5 results
Name | Type of Offering | Accepted Date |
---|---|---|
Prelude Corp
See All Filings
|
D | 2018-07-27 16:54:33 |
Amount To Be Raised
$8,999,991
Associated Brokers / Dealers
N/A
CIK Number
0001669317
Filed Document
0001382963-18-000121
Exclusions or Exemptions
506b
Accepted Date
2018-07-27 16:54:33
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Prelude Corp
See All Filings
|
D | 2022-02-15 17:13:56 |
Amount To Be Raised
$20,000,001
Associated Brokers / Dealers
N/A
CIK Number
0001669317
Filed Document
0001669317-22-000001
Exclusions or Exemptions
506b
Accepted Date
2022-02-15 17:13:56
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Prelude Corp
See All Filings
|
D | 2016-03-15 |
Amount To Be Raised
$3,000,000
Associated Brokers / Dealers
N/A
CIK Number
0001669317
Filed Document
0001382963-16-000159
Exclusions or Exemptions
506b
Accepted Date
2016-03-15
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Prelude Corp
See All Filings
|
D | 2017-03-15 16:53:30 |
Amount To Be Raised
$5,499,998
Associated Brokers / Dealers
N/A
CIK Number
0001669317
Filed Document
0001382963-17-000063
Exclusions or Exemptions
506b
Accepted Date
2017-03-15 16:53:30
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|
||
Prelude Corp
See All Filings
|
D | 2020-01-10 17:29:03 |
Amount To Be Raised
$10,000,013
Associated Brokers / Dealers
N/A
CIK Number
0001669317
Filed Document
0001382963-20-000002
Exclusions or Exemptions
506b
Accepted Date
2020-01-10 17:29:03
Type of Offering
D
Industry
Biotechnology
Offering Tier
N/A
Principal Place of Business
CALIFORNIA
Revenue or Assets
Decline to Disclose
Type of Security
Equity
|